Join
our team

Every day, a team of ambitious scientists and professionals at PolTREG works on development of innovative therapy for autoimmune disease, founded on our patented, proprietary method to increase the number of patients’ T-regulatory (TREG) cells. Our company is at an exciting growth stage, with clincal trials for treatment of diabletes and multiple sclerosis, a new manufacturing facility and promising progress on next generation of cell-based therapeutics.

If you want to create the future of medicine, join our Team.